We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock
OCEA

Delisted

OCEA was delisted on the 23rd of April, 2025.

Back to rankings

34 hedge funds and large institutions have $93.4M invested in Ocean Biomedical, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

31% more funds holding

Funds holding: 26 → 34 (+8)

14% more capital invested

Capital invested by funds: $81.8M → $93.4M (+$11.6M)

Holders
34
Holders Change
+8
Holders Change %
+30.77%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
3
Closed
1
Calls
$142K
Puts
–
Net Calls
+$142K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$7.99M
2
CCM
Context Capital Management
California
+$4.99M
3
SCC
Spring Creek Capital
Kansas
+$1.36M
4
Millennium Management
Millennium Management
New York
+$1M
5
AI
Arena Investors
New York
+$554K

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$588K
2
SV
Starboard Value
New York
-$212K
3
MSU
Mizuho Securities USA
New York
-$80.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Shaolin Capital Management
Florida
$8.04M +$7.99M +796,900 New
MSU
2
Mizuho Securities USA
New York
$7.42M -$80.3K -8,000 -1%
SCM
3
Saba Capital Management
New York
$7.4M +$76.6K +7,638 +1%
BCM
4
Beryl Capital Management
California
$6.79M – – –
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$6.05M – – –
BFM
6
Boothbay Fund Management
New York
$6.05M – – –
WAM
7
Weiss Asset Management
Massachusetts
$6.05M – – –
CCM
8
Context Capital Management
California
$5.02M +$4.99M +497,865 New
WAM
9
Wolverine Asset Management
Illinois
$4.71M +$361K +36,000 +8%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$4.54M – – –
MI
11
MMCAP International
Cayman Islands
$4.04M – – –
PC
12
Periscope Capital
Ontario, Canada
$3.87M – – –
WRBC
13
W.R. Berkley Corp
Connecticut
$3.71M – – –
Marshall Wace
14
Marshall Wace
United Kingdom
$2.8M – – –
KIM
15
Karpus Investment Management
New York
$2.6M +$103K +10,300 +4%
CH
16
CVI Holdings
Delaware
$2.59M +$79.7K +7,944 +3%
6CM
17
683 Capital Management
New York
$1.51M – – –
SV
18
Starboard Value
New York
$1.46M -$212K -21,135 -13%
SCC
19
Spring Creek Capital
Kansas
$1.37M +$1.36M +135,500 New
WA
20
Whitebox Advisors
Minnesota
$1.04M +$28.1K +2,800 +3%
Millennium Management
21
Millennium Management
New York
$1.01M +$1M +100,000 New
LA
22
Linden Advisors
New York
$792K – – –
PCM
23
Pinz Capital Management
New York
$605K – – –
AI
24
Arena Investors
New York
$556K +$554K +55,200 New
Walleye Capital
25
Walleye Capital
New York
$542K – – –
1
2

OCEA Hedge Fund Activity: Q1 2022 in Review

34 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q1 2022, worth a combined $93.4M — up 14% from $81.8M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new OCEA positions and 1 closed out — a net gain of 8 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $7.99M. The largest seller was AQR Arbitrage, cutting an estimated $588K.

  • 34 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q1 2022, up from 26 in Q4 2021.
  • Funds reported $93.4M of Ocean Biomedical, Inc. Common Stock stock for Q1 2022, up 14% quarter-over-quarter.
  • 9 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q1 2022 and 1 closed out, a net change of +8 holders.
  • The largest Ocean Biomedical, Inc. Common Stock buyer in Q1 2022 was Shaolin Capital Management, an estimated $7.99M added.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q1 2022 was AQR Arbitrage, an estimated $588K sold.

Based on aggregated 13F filings for Q1 2022.